You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科笛-B(02487.HK):CU-40102(外用非那雄胺噴霧劑)中國III期臨牀試驗結果獲中華醫學會第八屆毛髮學術會議接受以電子壁報形式展示
格隆匯 08-29 12:04

格隆匯8月29日丨科笛-B(02487.HK)發佈公吿,集團治療雄激素性脱髮產品CU-40102(外用非那雄胺噴霧劑)的中國III期臨牀試驗結果獲中華醫學會第八屆毛髮學術會議接受以電子壁報形式展示。

CU-40102是全球首個亦是唯一一個獲批用於雄激素性脱髮治療的外用非那雄胺產品,也是首個獲得中國國家藥品監督管理局(“國家藥監局”)受理NDA的外用非那雄胺。CU-40102在中國的III期註冊性臨牀試驗為一項多中心、隨機、雙盲、安慰劑對照的試驗,以評估CU-40102對中國成年男性雄激素性脱髮患者的療效及安全性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account